VM Pharma (TrkA Program) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

VM Pharma (TrkA Program) General Information


VM-902A pharmaceutical product. The asset is used to develop VM-902A which is orally bioavailable, peripherally acting and allosteric selective tropomyosin receptor kinase for recovering of many diseases in USA.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Primary Office
  • 45535 Northport Loop East
  • Fremont, CA 94538
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VM Pharma (TrkA Program) Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore VM Pharma (TrkA Program)‘s full profile, request access.

Request a free trial